Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.

The Journal of clinical psychiatry - 1 May 2010

Perlis Roy H, Adams David H, Fijal Bonnie, Sutton Virginia K, Farmen Mark, Breier Alan, Houston John P

Abstract excerpt

OBJECTIVE: To evaluate common genetic variations for association with symptomatic improvement in bipolar I depression following treatment with olanzapine/fluoxetine combination (OFC) or lamotrigine. METHOD: Symptom improvement was assessed in 88 OFC-treated and 85 lamotrigine-treated white patien...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Benzodiazepines
Share to Dopamine beta-Hydroxylase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluoxetine

Share to Lamotrigine

Share to Olanzapine

Share to Receptors, Dopamine D3

Share to Triazines

Source

Identifiers

PMID: 20021991
DOI: 10.4088/JCP.08m04632gre

Genes

HRH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20021991-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.PMID 20021991Read ↗

Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis.Semantic proximity Read ↗

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients.Semantic proximity Read ↗

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.Semantic proximity Read ↗

Histamine H4 receptor polymorphism: a potential predictor of risperidone efficacy.Semantic proximity Read ↗

Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication.Semantic proximity Read ↗

A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depressionSemantic proximity Read ↗

Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach.Semantic proximity Read ↗

Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.Semantic proximity Read ↗

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain.Semantic proximity Read ↗

High-throughput chemiluminometric genotyping of single nucleotide polymorphisms of histamine, serotonin, and adrenergic receptor genes.Semantic proximity Read ↗

Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies.Semantic proximity Read ↗

Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.